ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Does macular telangiectasia type 2 influence the retinal microvasculature in diabetic retinopathy?
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsTo evaluate the structural and microvascular characteristics of eyes with coexisting macular telangiectasia type 2 (MacTel) and non-proliferative diabetic retinopathy (NPDR) using optical coherence tomography (OCT) and OCT angiography (OCTA), and to explore how MacTel may influence retinal architecture and vascular integrity in diabetic eyes.
methodsThis retrospective cross-sectional study included 40 eyes with both MacTel and NPDR, 40 eyes with NPDR only, and 35 eyes from an age- and sex-matched control group. All participants underwent spectral-domain OCT and OCTA. Quantitative measurements of retinal layer thickness and vessel density in the superficial (SCP) and deep capillary plexuses (DCP) were compared between groups. Eye-level analyses were performed using linear mixed-effects models to account for inter-eye correlation.
resultsGroups were matched for age, diabetes duration, glycated hemoglobin, and NPDR stage (all p > 0.05). Mean BCVA was significantly worse in eyes with MacTel and NPDR compared with NPDR-only eyes (0.79 ± 0.64 vs. 0.34 ± 0.32 logMAR; p < 0.001). Retinal layer thicknesses within the inner temporal parafoveal region and central retinal thickness were significantly reduced in eyes with MacTel and NPDR (p < 0.05). Vessel density in both the SCP and DCP was significantly higher in the MacTel and NPDR group compared with NPDR-only eyes (p < 0.05). None of the eyes with MacTel showed proliferative diabetic retinopathy or diabetic macular edema.
conclusionsThis study provides the first quantitative evidence that MacTel modifies diabetic retinal pathology by attenuating microvascular injury while amplifying neurodegenerative thinning. The preservation of vessel density alongside pronounced retinal thinning and poorer vision suggests that MacTel alters the neurovascular balance of diabetic retinopathy.
Indexed as
Identifiers
42541560What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.